The pharmaceutical sector has been making headlines for large-scale layoffs, department closures and clinical trial failures.

The issuer is solely responsible for the content of this announcement. SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations Based on preliminary figures, SCHOTT Pharma expects ...

US drugmakers' shares drop 3% to 6% premarket European, Indian healthcare stocks drag down broader indexes Trump aims to shift pharma manufacturing to US, but analysts doubtful April 9 (Reuters ...